On the 10th local time, WHO held a routine press conference for new coronary pneumonia. WHO Assistant Director-General Marianjeira Simao said that WHO has evaluated the clinical data of China's Sinopharm's new crown vaccine and recognized the vaccine's effectiveness. Sex and safety.
The WHO conducted field inspections on vaccine production in January and February, and the production process was standardized.
Mariángela Simão pointed out that the national medicine vaccine is widely used worldwide and the vaccine is safe and effective.
Kate O'Brien, Director of Immunization, Vaccines and Biological Preparations of WHO, said that the Sinopharm vaccine is very effective in preventing severe illness and death. The vaccine requires two doses.
(Main station reporter Zhu He)